Search This Board: 
Created: 05/29/2002 04:20:10 PM - Followers: 91 - Board type: Free - Posts Today: 0



 Celldex Therapeutics, Inc. (CLDX)





Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Product Pipeline:
News and Press Releases:


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes
Events and Presentations:
SEC Filings:
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

yes November 8, 2016  yes

From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 







All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:



PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
Nobody here? This just keeps popping harry crumb 08/05/2022 12:30:07 PM
A whale knows when a bio is on harry crumb 07/19/2022 11:53:33 AM
More good news an the stock gets hammered. harry crumb 07/01/2022 10:22:46 AM
Whats the word on this freefall going on? harry crumb 05/31/2022 12:29:49 PM
Something is going to be announced real soon, harry crumb 09/02/2021 01:35:12 AM
#1861 Don't forget the additional $26,500,000 million they can add. make it happen 07/13/2021 07:45:17 AM
#1860 Another $175,000,000 raised in dilution... Share price depletes make it happen 07/13/2021 07:40:42 AM
#1859 W.e. let one switch how they want, if make it happen 07/13/2021 07:40:27 AM
#1858 Get lost, you got no clue who we harry crumb 07/13/2021 01:50:33 AM
#1857 Crumb showed up on IDRA years ago. He The Canes 07/12/2021 07:58:15 PM
#1856 2 R/S so far make it happen 07/12/2021 03:40:01 PM
#1855 Can trade in any direction and get burnt make it happen 07/12/2021 03:27:42 PM
#1854 Def make some either way you trade but make it happen 07/12/2021 03:26:33 PM
#1853 I have a great track record. I do The Canes 07/12/2021 02:38:46 PM
#1852 Lmao, someday you might learn how to trade, GL harry crumb 07/12/2021 01:04:48 PM
#1851 Great post! Truly 100% fact! Thats why we harry crumb 07/12/2021 01:03:31 PM
#1850 The Crumb said it. Post #1826. He bounces The Canes 07/12/2021 12:56:38 PM
#1849 That was back then, if course we shorted harry crumb 07/12/2021 12:22:24 PM
#1848 Who said that? Looks it by financials, Phase make it happen 07/12/2021 10:46:53 AM
#1847 May I quote your post from 7/14/20 "Looking The Canes 07/10/2021 02:00:51 PM
#1846 Bang! This could be the next fda fast harry crumb 07/10/2021 10:49:41 AM
#1845 This stock has quadrupled an nobody is harry crumb 06/28/2021 04:49:15 PM
#1844 Insiders are buying this up, they know good harry crumb 06/24/2021 09:58:01 AM
#1843 30 coming harry crumb 02/08/2021 11:55:12 PM
#1842 Back over 20, this is trading like it harry crumb 01/26/2021 12:35:26 PM
#1841 I prefer salami. Thanks alchemytrader 10/25/2020 08:14:10 PM
#1840 Bologna !!@!!! Emptyhead 10/25/2020 08:08:55 PM
#1839 i covered my 7.80 a long time ago. alchemytrader 10/24/2020 10:14:08 PM
#1838 U guys are lucky then. My average kratz 10/24/2020 10:06:55 PM
#1837 Somebody with the ability to manipulate wanted in interloper 10/14/2020 11:43:16 AM
#1836 Up .54 in AH Trading on low volume. interloper 10/14/2020 05:13:31 AM
#1835 Breakout chart. Oct 28 price breaks through previous interloper 10/07/2020 12:53:37 PM
#1834 18.46 broke but retraced. Looking good. interloper 10/06/2020 02:26:58 PM
#1833 Price went up and touched the Weekly 200MA, interloper 10/06/2020 01:20:57 PM
#1832 Woohoooooo! interloper 10/06/2020 12:57:00 PM
#1831 Oh damn! Another spike! If that’s how pounding interloper 10/06/2020 12:55:55 PM
#1830 How are those puts doing today? Wrong way Feldon. interloper 10/06/2020 12:41:53 PM
#1829 Look at the chart , that’s exactly what interloper 10/06/2020 12:40:33 PM
#1828 Breakdown! Lmao harry crumb 09/30/2020 12:27:35 PM
#1827 BREAKOUT! ! ! interloper 09/28/2020 03:31:12 PM
#1826 Looking good shorts, keep pounding it down, nothing harry crumb 07/14/2020 06:54:19 PM
#1825 This is just crazy, something is wrong, this harry crumb 06/30/2020 01:44:41 PM
#1824 Now we killn it fellow shorts, lets pound harry crumb 06/26/2020 11:07:57 AM
#1823 No brainer. Grandmasim 06/24/2020 06:42:23 AM
#1822 Therefore, shorting this turd to the max! $$$ harry crumb 06/24/2020 01:19:34 AM
#1821 I can see this at 2.50 again very harry crumb 06/24/2020 01:19:01 AM
#1820 Yup yup..rightfully so...hence Claytrader arriving. Grandmasim 06/20/2020 12:45:36 PM
#1819 It’s about to drop like hot potatoes, at rsconcept 06/20/2020 11:33:38 AM
#1818 Ikarian and RTW bought total of 17% shares investorguru2 06/19/2020 09:37:24 PM
#1817 I expect a hit piece very soon...couple that The Canes 06/19/2020 06:34:58 PM
Post Subject